Related references
Note: Only part of the references are listed.An acromegaly case treated with clomiphene citrate: add-on treatment in primary medical therapy
Esma Pehlivan Koroglu et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2023)
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview
Neha Bhatia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Managing Estrogen Therapy in the Pituitary Patient
Nicholas Shoung et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2023)
Trends in incidence and mortality risk for acromegaly in Norway: a cohort study
Camilla M. Falch et al.
ENDOCRINE (2023)
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States
Maria Fleseriu et al.
PITUITARY (2022)
A prospective study on the efficacy of oral estrogen in female patients with acromegaly
J. Magalhaes et al.
PITUITARY (2022)
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length
Francesco Cocchiara et al.
PITUITARY (2022)
Clinical Biology of the Pituitary Adenoma
Shlomo Melmed et al.
ENDOCRINE REVIEWS (2022)
A Novel Estrogen Receptor beta Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition
Ananya Banerjee et al.
CANCERS (2022)
Second line treatment of acromegaly: Pasireotide or Pegvisomant?
Sabrina Chiloiro et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review
Iga Zendran et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
Alessandro Mondin et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu et al.
PITUITARY (2021)
Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature
Jakob Dal et al.
CLINICAL ENDOCRINOLOGY (2021)
Genetic and Epigenetic Causes of Pituitary Adenomas
Mengqi Chang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The physiological role of estrogen receptor functional domains
Yukitomo Arao et al.
EXPLORING NUCLEAR RECEPTORS (2021)
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
Filippo Ceccato et al.
PITUITARY (2021)
Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report
Sasan Mirfakhraee et al.
JOURNAL OF MEDICAL CASE REPORTS (2021)
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model
M. Barbot et al.
NEUROSURGICAL REVIEW (2020)
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
MANAGEMENT OF ENDOCRINE DISEASE Does gender matter in the management of acromegaly?
Nele F. Lenders et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Pituitary Hyperplasia, Hormonal Changes and Prolactinoma Development in Males Exposed to Estrogens-An Insight From Translational Studies
Branka Sosic-Jurjevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?
Massimo Terzolo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo
Yanrong Qian et al.
CANCERS (2020)
Selective estrogen receptor modulators (SERMS): keys to understanding their function
James H. Liu
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Modulating Effects of Progesterone on Spontaneous Nocturnal and Ghrelin-Induced GH Secretion in Postmenopausal Women
Ferdinand Roelfsema et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Growth Hormone's Links to Cancer
Cesar Luiz Boguszewski et al.
ENDOCRINE REVIEWS (2019)
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly
F. Ferrau et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Epidemiology of acromegaly: review of population studies
Aikaterini Lavrentaki et al.
PITUITARY (2017)
Acromegaly is associated with increased cancer risk: a survey in Italy
Massimo Terzolo et al.
ENDOCRINE-RELATED CANCER (2017)
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
M. Victoria Recouvreux et al.
ENDOCRINOLOGY (2017)
Role of Growth Hormone in Breast Cancer
Ramadevi Subramani et al.
ENDOCRINOLOGY (2017)
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp- somatotropinomas
D. Regazzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry
Luigi Maione et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas
Maria Jose Garcia-Barrado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Somatostatin receptor ligands in the treatment of acromegaly
Monica R. Gadelha et al.
PITUITARY (2017)
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Felipe F. Casanueva et al.
PITUITARY (2017)
Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma
Jing-Jing Wang et al.
ONCOTARGET (2017)
Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications
Ching-Jen Chen et al.
ACTA NEUROCHIRURGICA (2017)
Sex steroids and the GH axis: Implications for the management of hypopituitarism
Vita Birzniece et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas
Cristina L. Ronchi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Unravelling exemestane: From biology to clinical prospects
Ana Filipa Sobral et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Growth hormone is permissive for neoplastic colon growth
Vera Chesnokova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol
Nwe Ni Than et al.
SYSTEMATIC REVIEWS (2016)
Estrogens and selective estrogen receptor modulators in acromegaly
Felipe H. Duarte et al.
ENDOCRINE (2016)
Somatostatin Is Essential for the Sexual Dimorphism of GH Secretion, Corticosteroid-Binding Globulin Production, and Corticosterone Levels in Mice
Jessica M. Adams et al.
ENDOCRINOLOGY (2015)
The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study
Tomas Thor Agustsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Selective estrogen receptor modulators in clinical practice: a safety overview
Amanda J. Ellis et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies
Felipe H. Duarte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013
Gudrun Thuridur Hoskuldsdottir et al.
PITUITARY (2015)
Growth hormone enhances LNCaP prostate cancer cell motility
Alona O. Nakonechnaya et al.
ENDOCRINE RESEARCH (2015)
Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis
Asli Sezgin Caglar et al.
ENDOCRINE (2015)
Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
Philippe J. Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
John D. Carmichael et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer
Karen Kar-Loen Chan et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Both Estrogen Receptor α and β Stimulate Pituitary GH Gene Expression
Dimiter Avtanski et al.
MOLECULAR ENDOCRINOLOGY (2014)
Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies
Jennifer C. Stone et al.
PITUITARY (2014)
Tamoxifen as a therapeutic agent in acromegaly
Irida Balili et al.
PITUITARY (2014)
Growth Hormone Potentiates 17β-Estradiol-Dependent Breast Cancer Cell Proliferation Independently of IGF-I Receptor Signaling
Dana L. Felice et al.
ENDOCRINOLOGY (2013)
Differential effects of exogenous and autocrine growth hormone on LNCaP prostate cancer cell proliferation and survival
Alona O. Nakonechnaya et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Prevalence and incidence of pituitary adenomas: a population based study in Malta
Mark Gruppetta et al.
PITUITARY (2013)
Gender Difference in the Neuroendocrine Regulation of Growth Hormone Axis by Selective Estrogen Receptor Modulators
Vita Birzniece et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Estrogen treatment for acromegaly
Ilan Shimon et al.
PITUITARY (2012)
Growth hormone affects gene expression and proliferation in human prostate cancer cells
M. Bidosee et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2011)
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines
D. Dworakowska et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Anastrozole
Catherine M. Kelly et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual
Katherine Garcia-Malpartida et al.
FERTILITY AND STERILITY (2010)
Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly?
Sophie Vallette et al.
PITUITARY (2010)
Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men
Johannes D. Veldhuis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Lung cancer risk associated with Thr495Pro polymorphism of GHR in chinese population
Guochun Cao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women
Petra Kok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis
A. Belizon et al.
DISEASES OF THE COLON & RECTUM (2007)
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling
Xiao Zhang et al.
CARCINOGENESIS (2007)
In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver
Oscar M. Vidal et al.
MOLECULAR ENDOCRINOLOGY (2007)
Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B
Jang Hyun Choi et al.
NATURE CELL BIOLOGY (2006)
Variants in the GH-IGF axis confer susceptibility to lung cancer
Matthew F. Rudd et al.
GENOME RESEARCH (2006)
Raloxifene decreases serum IGF-I in male patients with active acromegaly
EV Dimaraki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement
M Yan et al.
ENDOCRINOLOGY (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults
JD Veldhuis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro
GM Leong et al.
ENDOCRINOLOGY (2004)
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studies
G Tulipano et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Raloxifene lowers IGF-I levels in acromegalic women
R Attanasio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Estroprogestinic pill normalizes IGF-I levels in acromegalic women
R Cozzi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2
KC Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Global transcription profiling of estrogen activity: Estrogen receptor a regulates gene expression in the kidney
SA Jelinsky et al.
ENDOCRINOLOGY (2003)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis
MM Ramsey et al.
ENDOCRINOLOGY (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis
SM Swanson et al.
CARCINOGENESIS (2002)
Estrogen receptor (ER)-α, but not ER-β, mediates regulation of the insulin-like growth factor I gene by antiestrogens
B Fournier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen and androgen elicit growth hormone release via dissimilar patterns of hypothalamic neuropeptide secretion
HA Hassan et al.
STEROIDS (2001)
The role of STAT proteins in growth hormone signaling
J Herrington et al.
ONCOGENE (2000)
The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands
RM Blair et al.
TOXICOLOGICAL SCIENCES (2000)
Share Paper
